BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28761613)

  • 1. [DRESS syndrome secondary to antituberculosis drugs: about a case].
    Jridi S; Azzeddine R; Bourkadi JE
    Pan Afr Med J; 2017; 27():37. PubMed ID: 28761613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The "DRESS" syndrome in antituberculosis drugs].
    Bopaka RG; El Khattabi W; Afif H; Aichane A; Bouayad Z
    Rev Pneumol Clin; 2014 Jun; 70(3):185-8. PubMed ID: 24646784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Allergy Study (Intradermal, Patch, and Lymphocyte Transformation Tests) in a Case of Isoniazid-Induced DRESS.
    Arruti N; Villarreal O; Bernedo N; Audicana MT; Velasco M; Uriel O; Martinez A; Bellón T
    J Investig Allergol Clin Immunol; 2016; 26(2):119-20. PubMed ID: 27164631
    [No Abstract]   [Full Text] [Related]  

  • 4. Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report.
    Wang L; Li LF
    Medicine (Baltimore); 2017 Mar; 96(11):e6346. PubMed ID: 28296768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature.
    Coster A; Aerts O; Herman A; Marot L; Horst N; Kenyon C; Vlieghe E; Hainaut P; Baeck M
    Contact Dermatitis; 2019 Nov; 81(5):325-331. PubMed ID: 31021423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DRESS syndrome secondary to pyrazinamide: An uncommon complication of tuberculosis treatment].
    Kombila UD; Ka W; Mbaye FBR; Diouf NF; Fall L; Ouedraogo P; Koutonin ANE; Dia Kane Y; Oumar Toure Badiane N
    Rev Mal Respir; 2018 Jan; 35(1):69-73. PubMed ID: 29429561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications.
    Cheng J; Rawal S; Roberts A; Guttman OR
    Pediatr Infect Dis J; 2013 Dec; 32(12):1388-90. PubMed ID: 24569311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitubercular therapy - an uncommon side effect.
    Kapur M; Gupta N; Gupta NK; Chakrabarti S; Kumar R; Ish P
    Adv Respir Med; 2021; 89(5):544-545. PubMed ID: 34725810
    [No Abstract]   [Full Text] [Related]  

  • 9. Two cases of tuberculosis with multiple drug hypersensitivity after drug-induced hypersensitivity syndrome.
    Sekine A; Saito T; Ito S; Tsunoda Y; Sumazaki Y; Tanaka T; Takoi H; Lin SY; Yatagai Y; Hayasihara K
    Respir Investig; 2012 Jun; 50(2):70-5. PubMed ID: 22749254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: case report
.
    Kim H; Bang ES; Lim SK; Lee JM
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):808-15. PubMed ID: 27443659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRESS syndrome with cerebral vasculitis.
    Sola D; Rossi L; Sainaghi PP; Pirisi M
    Intern Med; 2013; 52(12):1403-5. PubMed ID: 23774556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to antituberculosis drugs presenting as DRESS syndrome and acute liver failure.
    Carlin Ronquillo A; Alvizuri Gómez C; García-Encinas C
    Rev Gastroenterol Peru; 2022; 42(2):136-138. PubMed ID: 36513361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7).
    Draz N; Datta S; Webster DP; Cropley I
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23904426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antituberculosis Drug-Associated DRESS: A Case Series.
    Allouchery M; Logerot S; Cottin J; Pralong P; Villier C; Ben Saïd B;
    J Allergy Clin Immunol Pract; 2018; 6(4):1373-1380. PubMed ID: 29274824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) induced by antituberculous treatment.
    Kwas H; Guermazi E; Khouaja I; Khattab A; Zendah I; Ghédira H
    Tunis Med; 2016 Dec; 94(12):900. PubMed ID: 28994898
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.
    Karakayalı B; Yazar AS; Çakir D; Cetemen A; Kariminikoo M; Deliloglu B; Guven S; Islek I
    Pan Afr Med J; 2017; 28():218. PubMed ID: 29629004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
    Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
    J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
    Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
    Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome due to ethambutol.
    Gest N; Ingen-Housz-Oro S; Gener G; Bellanger M; Henn A; Gallien S; Flateau C
    Med Mal Infect; 2018 Jun; 48(4):302-305. PubMed ID: 29602678
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man.
    Shebe K; Ngwanya MR; Gantsho N; Lehloenya RJ
    Contact Dermatitis; 2014 Feb; 70(2):125-7. PubMed ID: 24450829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.